Aisling Capital
- USA
- United Kingdom
- Switzerland
- Canada
- Germany
- France
- Italy
- Spain
- Belgium
- Netherlands
- Austria
- Luxembourg
- Sweden
- Denmark
- Ireland
- Norway
- Finland
- Portugal
- Greece
- Malta
- Liechtenstein
- Monaco
- San Marino
- Andorra
- Seed
- Series A
- Series B
- Series C
- Pharma
- Consumer Products
- Diagnostics
- Medical Devices
- Service
A New York-based healthcare investment firm founded in 2000. Aisling Capital focuses on innovative healthcare products, pharmaceutical and biotech solutions, and medical technologies. With over $1.8 billion raised across four funds and a team of seasoned professionals, they back both private and public-stage companies with deep clinical and financial expertise.
Investment Thesis
Manager's Experience
Portfolio
Aclaris Therapeutics
Inc.
Adams Respiratory Therapeutics
Inc.
ADMA Biologics
Inc.
Advion
Inc.
Aeglea BioTherapeutics
Inc.
Agile Therapeutics
Inc.
Aimmune Therapeutics
Inc.
Ajax Health
Allos Therapeutics
Inc.
Ambit Biosciences Corporation
Antios Therapeutics
Aragon Pharmaceuticals
Inc.
Archimica Cooperatief U.A.
Arcus Biosciences
Inc.
ARMGO Pharma
Inc.
ARMO BioSciences
Inc.
Ascendis Pharma A/S
Aton Pharma
Inc.
Atreca
Inc.
Audentes Therapeutics
Inc.
Auxilium Pharmaceuticals
Inc.
AVANZA Laboratories
LLC
AVROBIO
Inc.
Axcan Pharma
Inc.
Barrier Therapeutics
Inc.
Bicara Therapeutics
Bioenvision
Inc.
Biohaven Pharmaceuticals Ltd.
Biomea Fusion
Inc.
BridgeBio Pharma LLC
CalciMedica
Inc.
Cardiokine
Inc.
Catalent
Inc.
Cempra
Inc.
Chimerix
Inc.
Cidara Therapeutics
Inc.
Clovis Oncology
Inc.
CollaGenex Pharmaceuticals
Inc.
Colorescience
Inc.
COMPASS Pathways
Cynapsus Therapeutics Inc.
Cytos Biotechnology AG
Dermira
Inc.
Dren Bio
Durata Therapeutics
Inc.
EarLens Corporation
Eidos Therapeutics
Elevation Oncology
Inc.
Esperion Therapeutics
Inc.
F2G Limited
Forge Biologics
Garuda Therapeutics
Inc.
Global Blood Therapeutics
Inc.
GTx
Inc.
Harmony Biosciences
LLC
Ibrutinib Royalty
Infinity Pharmaceuticals
Inc.
Intercept Pharmaceuticals
Inc.
Intersect ENT
Inc.
LENSAR
Inc.
Lombard Medical
Inc.
Loxo Oncology
Inc.
MAP Pharmaceuticals
Inc.
Marker Therapeutics
Inc.
MKG LLC
MEI Pharma
Inc.
Menlo Therapeutics Inc.
Mindful Health Solutions
Miramar Labs
Inc.
Monte Rosa Therapeutics
Inc.
Myogen
Inc.
Nabriva
NextWave Pharmaceuticals
Inc.
Novazyme Pharmaceuticals
Inc.
Nuvation Bio
Inc.
ObsEva SA
Oculex Pharmaceuticals
Inc.
Paratek Pharmaceuticals
Inc.
PellePharm
Pernix Therapeutics
Inc.
Pharmaron
Inc.
Planet Biopharmaceuticals
Inc.
Poseida Therapeutics
Inc.
PowerVision
Inc.
PreCision Dermatology
Inc.
Prolacta Bioscience
Inc.
Promentis Pharmaceuticals
Inc.
Protagonist Therapeutics
Inc.
Quintiles Transnational Holdings Inc.
Reneo Pharmaceuticals
Inc.
Roka Bioscience
Inc.
Seragon Pharmaceuticals
Inc.
Sirion Therapeutics
Inc.
SkinMedica
Inc.
Sorrento Therapeutics
Inc.
Spirox
Inc.
Spruce Biosciences
Spyre Therapeutics
Syndax Pharmaceuticals
Inc.
Synergy Pharmaceuticals Inc.
Syros Pharmaceuticals
Inc.
T2 Biosystems
Inc.
Talaris Therapeutics
Inc.
Topaz Pharmaceuticals
Inc.
TransEnterix
Inc.
Treeline Biosciences
Inc.
TRIA Beauty
Inc.
Verona Pharma plc
Versartis
Inc.
ViewRay
Inc.
Viracta Pharmaceuticals
Inc.
VIVUS
Inc.
Wugen
Inc.
Zavante Therapeutics
Inc.
ZELTIQ Aesthetics
Inc.
Zosano Pharma Corporation